Biocon Biologics Limited, a unit of India’s largest biopharmaceutical company Biocon, is in talks with Asia-focused Baring Private Equity (PE) Asia to raise funding in lieu of a minority stake, multiple sources familiar with the matter told DealStreetAsia.
While the exact deal size could not be ascertained, it could be around $100 million or even more, they added.
